According to this latest study, the 2021 growth of N-Acetylneuraminic Acid (CAS 131-48-6) will have significant change from previous year. By the most conservative estimates of global N-Acetylneuraminic Acid (CAS 131-48-6) market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the N-Acetylneuraminic Acid (CAS 131-48-6) market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of N-Acetylneuraminic Acid (CAS 131-48-6) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity 97%
Purity 98%
Purity 99%
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Food Additives
Pharmaceutical
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Combi-Blocks
AB Enterprises
Selleck Chemicals
Wilshire Technologies
Merck
Alichem
BLD Pharmatech
Oakwood Products
Achemo
Biosynth Carbosynth
Glentham Life Sciences
Tokyo Chemical Industry (TCI)